Strontium ranelate cuts vertebral fracture risk.(Gynecology)

From: OB GYN News | Date: November 1, 2005| Author: Jancin, Bruce | Copyright information

VIENNA -- Strontium ranelate reduced the risk of new vertebral fractures 41% over 3 years in a very-high-risk population of osteoporotic women with at least two prevalent vertebral fractures at baseline, Sergio Ortolani, M.D., reported at the annual European congress of rheumatology.

That's as robust a relative risk reduction as seen in much lower-risk postmenopausal osteoporotic women with no previous vertebral fractures, noted Dr. Ortolani of the Center for Metabolic B...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

Strontium ranelate prevented vertebral fractures: risk reduction was the greatest in a very-high-risk population of women with osteoporosis.(Rx)
Internal Medicine News ; VIENNA -- Strontium ranelate reduced the risk of new vertebral fractures by 41% over 3 years in a very-high-risk population of osteoporotic women with at least two prevalent vertebral fractures at baseline, Sergio Ortolani, M.D., reported at the annual European congress of rheumatology. That's
Strontium compound prevents some fractures.(Good to the bone)
Science News ; An experimental drug containing strontium makes bones denser and decreases the risk of fractures, a study of elderly women finds. The results add the drug, called strontium ranelate, to a wave of new treatments for osteoporosis. Strontium, a soft metal with chemical similarities to calcium, is
A potential new weapon in the fight against osteoporosis
Oakland Tribune ; AS a weapon against osteoporosis, the drug's beginnings were inauspicious -- it was shelved for almost 50 years, and its main component is a mineral widely regarded as nonessential. But the compound could become a potent treatment for the bone-thinning disorder affecting millions of Americans.
The Burden and Management of Vertebral Fractures
Journal of Psychosomatic Obstetrics and Gynecology ; LS2 Pierre Delmas University Claude Bernard Vertebral fractures account for approximately half of fragility fractures occurring in postmenopausal women. They are responsible for an excess of mortality similar to that after hip fractures. They are associated with significant morbidity which is
The silent enemy: no one is immune to osteoporosis--but what can you do about it? A new therapy may help.
Paraplegia News ; [ILLUSTRATION OMITTED] I've been a wheelchair user for more than 34 years and have always considered myself pretty healthy--at least as healthy as someone with C5 quadriplegia can be. I exercise on a dally basis, usually every other day with an ergometer (a hand-crank machine) I run at full speed
Strontium on comeback for osteoporosis.(Musculoskeletal Disorders)
Family Practice News ; SAN ANTONIO -- The older generation osteoporosis drug, strontium ranelate, is receiving renewed attention as a result of a metaanalysis showing that it reduces fracture rates in postmenopausal women as well as bisphosphonates do. Like bisphosphonates, strontium ranelate inhibits bone resorption but
Drug Watch
Formulary ; A HEADS-UP ON PHARMACEUTICALS IN LATE-STAGE DEVELOPMENT Selected literature * lbandrotiate. Stakkestad JA, Benevolenskaya Ll, Stepan JJ, et al, and the lbandronate Intravenous Study Group. Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in
Augmentation procedures for osteoporotic vertebral fractures--an ongoing experiment or emerging standard of care?(Editorial)
Southern Medical Journal ; The history of vertebral augmentation procedures is an interesting one. Vertebroplasty was first performed in France in 1984 and reported in a French language journal in 1987. (1) This publication did not create great international attention, but served to initiate further investigation by others.
One-Third of Vertebral Fractures Get Missed. (Radiologists' Reports Often Ambiguous).(Brief Article)
Internal Medicine News ; PHOENIX -- One-third of vertebral fractures evident on lateral x-ray are missed by radiologists or reported in an ambiguous manner to the primary care physician, according to the results of a multinational study The rate of missed findings and spurious reports was even higher, at 41%, when the
Bazedoxifene helps reduce vertebral fracture risk after menopause.(Endocrinology)
Internal Medicine News ; ... Osteoporotic Women 20mg bazedoxifene 2.3% 40mg bazedoxifene 2.5% 60mg raloxifene 2.3% Placebo 4.1% Note: Based on a randomized study of 36 months' treatment in 7,492 women. Source: Dr. Silverman ELSEVIER GLOBAL MEDICAL NEWS Note: Table made from bar graph.